162 related articles for article (PubMed ID: 27933142)
1. Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic
Zhang B; Li Q; Chu X; Sun S; Chen S
Transl Neurodegener; 2016; 5():21. PubMed ID: 27933142
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
3. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
[TBL] [Abstract][Full Text] [Related]
4. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
5. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
[TBL] [Abstract][Full Text] [Related]
6. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro.
Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q
J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328
[TBL] [Abstract][Full Text] [Related]
7. Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling.
Yang C; Li X; Gao W; Wang Q; Zhang L; Li Y; Li L; Zhang L
Front Pharmacol; 2018; 9():682. PubMed ID: 29997510
[TBL] [Abstract][Full Text] [Related]
8. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β.
Kawakami F; Suzuki M; Shimada N; Kagiya G; Ohta E; Tamura K; Maruyama H; Ichikawa T
FEBS J; 2011 Dec; 278(24):4895-904. PubMed ID: 21985244
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of salidroside through PI3K/Akt pathway activation in Alzheimer's disease models.
Zhang B; Wang Y; Li H; Xiong R; Zhao Z; Chu X; Li Q; Sun S; Chen S
Drug Des Devel Ther; 2016; 10():1335-43. PubMed ID: 27103787
[TBL] [Abstract][Full Text] [Related]
12. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
Leroy K; Yilmaz Z; Brion JP
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
[TBL] [Abstract][Full Text] [Related]
14. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
15. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
Hu M; Waring JF; Gopalakrishnan M; Li J
J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
[TBL] [Abstract][Full Text] [Related]
16. Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk.
Mateo I; Vázquez-Higuera JL; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; García-Gorostiaga I; Berciano J; Combarros O
Acta Neurol Scand; 2009 Aug; 120(2):130-3. PubMed ID: 19154537
[TBL] [Abstract][Full Text] [Related]
17. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
18. miR-23b-3p rescues cognition in Alzheimer's disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways.
Jiang H; Liu J; Guo S; Zeng L; Cai Z; Zhang J; Wang L; Li Z; Liu R
Mol Ther Nucleic Acids; 2022 Jun; 28():539-557. PubMed ID: 35592504
[TBL] [Abstract][Full Text] [Related]
19. Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice.
Zhang Y; Ma RH; Li XC; Zhang JY; Shi HR; Wei W; Luo DJ; Wang Q; Wang JZ; Liu GP
Front Aging Neurosci; 2014; 6():123. PubMed ID: 24987368
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.
Zhang YJ; Xu YF; Liu YH; Yin J; Wang JZ
FEBS Lett; 2005 Nov; 579(27):6230-6. PubMed ID: 16253246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
